Cambryn Biologics

Cambryn Biologics was a private U.S. biotherapeutics company focused on developing, manufacturing, and commercializing plasma-derived biologic products for clotting factor deficiencies and related hemostatic applications. The company specialized in extraction and purification of human plasma proteins and described a product cascade that included fibrinogen concentrate, immunoglobulin G, alpha-1 proteinase inhibitor, factor XI concentrate, and prothrombin concentrate. Cambryn also operated a cGMP-oriented manufacturing facility in Sarasota, Florida, and positioned itself as a contract manufacturing organization for biologically based raw materials derived primarily from human plasma. Public business registry records indicate the Florida registration became inactive, and there is limited recent evidence of ongoing operating activity. Overall, Cambryn appears to have been an early-stage plasma biologics developer/manufacturer rather than a clinically advanced therapeutic company.